[Toxoplasma gondii. Infection and its prevention].
D000818:Animals; D000917:Antibody Formation; D002415:Cats; D002825:Chorioretinitis / Q000209:etiology; D002908:Chronic Disease; D003168:Complement Fixation Tests; D004199:Disease Vectors; D004357:Drug Synergism; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D006849:Hydrocephalus / Q000209:etiology; D007111:Immunity, Cellular; D008607:Intellectual Disability / Q000209:etiology; D007565:Jaundice / Q000209:etiology; D007774:Lactation; D007933:Leucomycins / Q000627:therapeutic use; D008264:Macrophages / Q000276:immunology; D051379:Mice; D011247:Pregnancy; D011739:Pyrimethamine / Q000627:therapeutic use; D013154:Spleen / Q000166:cytology; D013449:Sulfonamides / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology; D014123:Toxoplasmosis / Q000635:transmission; D014295:Trimethoprim / Q000627:therapeutic use; D014774:Virulence
D007933:Leucomycins; D013449:Sulfonamides; D014295:Trimethoprim; D011739:Pyrimethamine
Toxoplasma gondii. Infektion und Infektabwehr.